- Home
- MYGN vs FBNC Comparison
MYGN vs FBNC Comparison
Compare MYGN & FBNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- FBNC
- Stock Information
- Founded
- MYGN 1991
- FBNC 1934
- Country
- MYGN United States
- FBNC United States
- Employees
- MYGN N/A
- FBNC N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- FBNC Major Banks
- Sector
- MYGN Health Care
- FBNC Finance
- Exchange
- MYGN Nasdaq
- FBNC Nasdaq
- Market Cap
- MYGN 2.0B
- FBNC 1.7B
- IPO Year
- MYGN 1995
- FBNC N/A
- Fundamental
- Price
- MYGN $13.69
- FBNC $45.94
- Analyst Decision
- MYGN Hold
- FBNC Buy
- Analyst Count
- MYGN 12
- FBNC 1
- Target Price
- MYGN $23.92
- FBNC $56.00
- AVG Volume (30 Days)
- MYGN 904.0K
- FBNC 192.8K
- Earning Date
- MYGN 11-07-2024
- FBNC 01-22-2025
- Dividend Yield
- MYGN N/A
- FBNC 1.85%
- EPS Growth
- MYGN N/A
- FBNC N/A
- EPS
- MYGN N/A
- FBNC 2.48
- Revenue
- MYGN $823,600,000.00
- FBNC $362,644,000.00
- Revenue This Year
- MYGN $13.82
- FBNC N/A
- Revenue Next Year
- MYGN $4.59
- FBNC $9.87
- P/E Ratio
- MYGN N/A
- FBNC $19.10
- Revenue Growth
- MYGN 12.15
- FBNC N/A
- 52 Week Low
- MYGN $13.81
- FBNC $29.53
- 52 Week High
- MYGN $29.30
- FBNC $50.34
- Technical
- Relative Strength Index (RSI)
- MYGN 26.49
- FBNC 54.75
- Support Level
- MYGN $13.92
- FBNC $47.06
- Resistance Level
- MYGN $15.44
- FBNC $48.18
- Average True Range (ATR)
- MYGN 0.79
- FBNC 0.99
- MACD
- MYGN 0.03
- FBNC -0.20
- Stochastic Oscillator
- MYGN 3.06
- FBNC 39.88
About MYGN Myriad Genetics Inc.
Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel with the capability to identify the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm offers biomarker discovery and companion diagnostic services to pharma and biotech companies.
About FBNC First Bancorp
First Bancorp is a bank holding company. The company is engaged in providing commercial and consumer banking services, mortgage lending, SBA lending, accounts receivable financing, and investment advisory services.